Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines

Journal of the American Board of Family Medicine

Volumn 21, Issue 6, 2008, Pages 512-521

  Jackson, James H ^a   Sobolski, John ^b   Krienke, Russ ^c   Wong, Ken S ^d   Frech Tamas, Feride ^d   Nightengale, Brian ^a  

^a XCENDA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Austin Regional Clinic   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE ORGANIZATION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; UNITED STATES;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SYSTOLE; TIME FACTORS; UNITED STATES;

EID: 56749174059     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2008.06.080025     Document Type: Article

References (14)

1. American Heart Association. Heart disease and stroke statistics - 2008 update. Dallas (TX): American Heart Association; 2008:18-9.
2. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among US adults, 1988-1994. Am J Prev Med 2002;22:43-9.
3. Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002;25:134-47.
4. Moser M. From JNC I to JNC 7 - what have we learned? Progr Cardiovasc Dis 2006;48:303-15.
5. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
6. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
7. Maue SK, Jackson JH, Weiss BA, Rivo ML, Jhaveri V, Lennert B. The hypertension management program: identifying opportunities for improvement. J Clin Hypertens 2003;5(3 suppl 2):33-40.
8. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75.
9. National Committee for Quality Assurance. Healthcare Effectiveness Data and Information Set 2007. Washington, DC: National Committee for Quality Assurance; 2006.
10. Wang Y. Lack of effect of guideline changes on hypertension control for patients with diabetes in the US, 1995-2005. Diabetes Care 2007;30:49-52.
11. Andros V, Egger A, Dua U. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes. JMCP 2006;12:303-9.
12. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002;4:393-404.
13. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
14. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002;24:302-16.